Mental Health Book

Amphetamine Use Disorders

Marijuna

Opioid

Hallucinogen Use Disorders

Background Information

Alcohol Use Disorders

GHB

Inhalants

Marijuana

Compulsive Behavior

Sedative Abuse

Tobacco Use Disorders

Ophthalmology Chapter related topics

Pathology and Laboratory Medicine Chapter related topics

Neurology Chapter related topics

Obstetrics Chapter related topics

Pediatrics Chapter related topics

Examination Chapter related topics

Sports Medicine Chapter related topics

Pharmacology Chapter related topics

Dermatology Chapter related topics

http://www.fpnotebook.com/

Hallucinogen

Aka: Hallucinogen, Lysergic Acid, LSD, Mescaline, Psilocybin
Advertisement
  1. See Also
    1. Chemical Dependency
    2. Substance Abuse Evaluation
  2. Background
    1. Derivations
      1. LSD semisynthetically derived from ergot alkaloids
      2. Mescaline naturally derived from peyote
      3. Psilocybin naturally derived from Psilocybe
    2. Pharmacokinetics
      1. LSD (50-400 ug): 8-12 hour duration
      2. Mescaline (250-600 mg): 8-12 hour duration
      3. Psilocybin (10-50 mg): 6-8 hour duration
  3. Forms or Street Names
    1. Lysergic Acid Diethylamide (LSD)
      1. Acid
      2. Sugar
      3. Cubes
      4. Trips
      5. Windowpane
      6. Blotter
    2. Mescaline
      1. Buttons
      2. Beans
      3. Cactus
    3. Psilocybin
      1. Magic Mushrooms
      2. Mushroom
      3. Los ninos
  4. Signs
    1. Hyper-suggestible state
  5. Toxicity: Amphetamine-like reaction
    1. Hyperthermia
    2. Rhabdomyolysis
    3. Severe Hyponatremia
    4. Cerebral Infarction
  6. Toxicity Management
    1. Provide calm and supportive environment

Hallucinogen Use Disorders (C0018532)

Concepts Mental or Behavioral Dysfunction (T048)
English Hallucinogen use disorder, Hallucinogen Use Disorders
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Lysergic Acid Diethylamide (C0024334)

Definition (MSH) Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
Definition (CSP) semisynthetic derivative of ergot; it has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover; it is a potent hallucinogen and psychotomimetic.
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121) , Hazardous or Poisonous Substance (T131)
MSH D008238
SnomedCT 15698006
English Diethylamide, Lysergic Acid, LSD, LSD 25, LSD-25, Lysergic Acid Diethylamide, Lysergide, Acid Diethylamide, Lysergic, lysergic acid diethylamide, Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-, LSD - D-Lysergic acid, D-Lysergic acid, LYSERGIDE, D-Lysergic Acid Diethylamide, LYSERGIC ACID, Lysergic Acid Diethylamide [Chemical/Ingredient], Lysergate diethylamide, lysergic acid diethylamide (LSD), lsd-25, lysergide, Lysergic acid diethylamide, Lysergic acid diethylamide (substance), LSD (Drug)
Swedish LSD
Czech diethylamid kyseliny lysergové, LSD
Finnish Lysergihapon dietyyliamidi
Russian LIZERGID, LIZERGINOVOI KISLOTY DIETILAMID, LSD, ЛИЗЕРГИД, ЛИЗЕРГИНОВОЙ КИСЛОТЫ ДИЭТИЛАМИД, ЛСД
French LSD, Lysergide
Italian LSD, Lisergide, LSD-25, Dietilammide dell'acido lisergico
Polish Dietyloamid kwasu lizergowego, Dwuetyloamid kwasu lizergowego
Japanese リセルギド, リセルグ酸ジエチルアミド, リゼルギン酸ジエチルアミド
Spanish dietilamida de ácido lisérgico (sustancia), dietilamida de ácido lisérgico, lisergida, LSD, Dietilamida del Acido Lisergico, Lisergida, Dietilamida del Ácido Lisérgico
German LSD, Lysergid, Lysergsäurediethylamid
Portuguese LSD, Dietilamida do Ácido Lisérgico, Lisergida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Mescaline (C0025460)

Definition (MSH) Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.
Concepts Organic Chemical (T109) , Hazardous or Poisonous Substance (T131)
MSH D008635
SnomedCT 229008008, 373780001, 83192000
English Mescaline, Trimethoxyphenethylamine, mescaline, Benzeneethanamine, 3,4,5-trimethoxy-, 3,4,5-Trimethoxyphenethylamine, Mescalin substance of abuse, Peyote extract, Mescalin, Mescalin substance of abuse (substance), mescaline in any form, Mescaline [Chemical/Ingredient], mescalin, Mescaline (product), Mescaline (substance)
Swedish Meskalin
Czech meskalin
Spanish mescalina, sustancia de abuso (sustancia), mescalina, sustancia de abuso, extracto de peyote, mescalina (producto), mescalina (sustancia), mescalina, Mescalina, Peyotl, Trimetoxifenetil Amina
Finnish Meskaliini
Russian MEZKALIN, MESKALIN, PEIOT, TRIMETOKSIFENETILAMIN, МЕЗКАЛИН, МЕСКАЛИН, ПЕИОТ, ПЕЙОТ, ТРИМЕТОКСИФЕНЕТИЛАМИН
Japanese メズカリン, メスカリン, メッカリン, ペヨーテ, トリメトキシフェネチルアミン
Croatian MESKALIN
Polish Meskalina
French Mescaline
German Mescalin, Trimethoxyphenethylamin
Italian Mescalina
Portuguese Mescalina, Peyote, Peyotl, Trimetoxifenetilamina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree